Current European Society of Cardiology Guidelines recommend concomitant atrial fibrillation (AF) ablation for all symptomatic patients undergoing other cardiac surgeries, but the safety and potential benefits of concomitant atrial fibrillation (AF) ablation at the time of double valve replacement remains unexamined. A retrospective review of patients with AF who underwent double valve replacement with or without concomitant surgical ablation in our institute starting from April 2006.
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
mortality
Timeframe: from the date of the surgery until the date of death, assess up to 120 months
sinus rhythm rate
Timeframe: from 6 months after surgery until the date of first documented progression or date of death from any cause, assess up to 120 months
stroke
Timeframe: from the date of surgery until the date of first documented progression or date of death from any cause, assess up to 120 months
third degree heart block requiring permanent pacemaker implantation
Timeframe: from the date of surgery until the date of first documented progression or date of death from any cause, assess up to 120 months